$RFAIR

RFAIR Price History for RF Acquisition Corp II Right Stock

This article provides an in-depth look at the price history of RF Acquisition Corp II Right (RFAIR) stock, including daily prices, trade data, and corporate actions. It details 52-week key points, new highs, and new lows, offering investors tools for historical data analysis and performance tracking. The content is provided by Barchart.com, which also offers various membership levels for enhanced data access.

Original reporting
Published Apr 28, 2026, 2:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 28, 2026, 2:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RFAIR
Neutral
medium confidence
Mentioned
$RFAIR
Relevance
6/10
AlphAI data visualization · based on Barchart.com
Decision brief

The 30-second read

$RFAIRNeutralLow
01

Why it matters

Limited immediate trading impact; primarily useful for historical analysis and trend assessment.

02

Market read

Low relevance for short-term trading; more suitable for long-term investors monitoring historical performance.

03

What to watch

Potential upcoming corporate actions or news could significantly alter the stock's trajectory, but are not covered in the current data.

Relevance 6/10Timing: long-term

Background

The article summarizes the stock's historical performance, including key price points and corporate actions, but lacks recent news or earnings data.

Company-level read

Ticker impact

$RFAIRNeutralMedium confidence
Context

The article provides historical price data and corporate actions for RF Acquisition Corp II Right (RFAIR), but does not include current price or volume data, limiting immediate trading signals.

Expected impact

Given the historical volatility and neutral sentiment, expect sideways trading with potential for short-term swings.

Evidence & confidence

Historical data shows volatility without clear trend; lack of recent news or catalysts limits predictive confidence.

Market effects

Limited impact on broader financial markets due to focus on historical stock data.

Minimal regional effects expected.

Negligible

Counterpoint

Historical volatility may present trading opportunities for short-term traders exploiting swings.

Key entities

  • RF Acquisition Corp II Right

    A rights offering related to RF Acquisition Corp II.

Related articles

$MRNAHigh

MRNA Stock’s Vaccine Rally Cracks As Worst Week In 3 Months Looms — Analyst Calls It A ‘Do-Not-Trade’ Over Wild Swings

Moderna (MRNA) shares fell sharply, marking their worst week in three months. Analysts from Bernstein, TD Cowen, and BMO Capital Markets expressed mixed views on the company's cancer vaccine data, with price targets implying significant downside. Moderna reported a revenue decline in 2025 and aims for cash breakeven by 2028. Earnings are due on Nov. 6. Retail sentiment on Stocktwits remains bullish for both Moderna and Merck (MRK).

$RIOMed

Rio Tinto to invest USD1.9 billion in Kangwinan bauxite project

Rio Tinto PLC and Ltd will invest USD1.9 billion in the Kangwinan bauxite project in Queensland, Australia. The project aims to add 20 million tonnes of annual bauxite production capacity by 2032, replacing output from the Andoom mine. Construction is set to ramp up in 2027, supporting 1,300 jobs. Shares in Rio Tinto fell 2.2% to AUD147.05 in Sydney on Friday morning, according to the company and Alliance News.

$VERAMedAI 8/10

Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results

Vera Therapeutics (VERA) reported strong Phase III results for TRUTAKNA (atacicept) in IgA nephropathy, with mild/moderate adverse events and no serious safety concerns. The drug received accelerated FDA approval in July and is being commercially launched. Vera plans to submit a supplemental biologics license application this quarter, aiming for full approval in mid-2027.

$INTCHigh

KOSPI Breaks Below 5,400 as Philadelphia Semiconductor Index Plunges 6.7%; SK Hynix's Solidigm IPO Halt Fails to Lift Sentiment

South Korea's KOSPI and KOSDAQ indices fell over 4% as U.S. semiconductor stocks plunged 6.7%, driven by foreign selling. SK Hynix halted Solidigm's IPO, citing market conditions. Samsung Electronics and SK Hynix shares dropped 4% and 3%, respectively. Meta's AI spending plans also weighed on sentiment, with oil prices rising on geopolitical tensions.